Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Diabetes

  Free Subscription


15.10.2018

3 Acta Ophthalmol
4 Am J Ophthalmol
1 Biochem Biophys Res Commun
2 Diabet Med
4 Diabetes
8 Diabetes Care
2 Diabetes Educ
10 Diabetes Obes Metab
5 Diabetologia
3 J Am Coll Cardiol
1 J Autoimmun
1 J Clin Endocrinol Metab
6 J Diabetes Complications
2 JAMA
5 Lancet
4 Lancet Diabetes Endocrinol
1 Med Care
1 N Engl J Med
2 Nat Genet
1 Ophthalmology
6 Pediatr Diabetes
1 PLoS Med
7 PLoS One
2 Proc Natl Acad Sci U S A
4 Retina


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Ophthalmol

  1. GRAUSLUND J, Andersen N, Andresen J, Flesner P, et al
    Evidence-based Danish guidelines for screening of diabetic retinopathy.
    Acta Ophthalmol. 2018 Oct 11. doi: 10.1111/aos.13936.
    PubMed     Text format     Abstract available

  2. POSCH-PERTL L, Michelitsch M, Schwetz V, Gasser-Steiner V, et al
    Change in choroidal volume after dexamethasone intravitreal implant in eyes with diabetic macular oedema.
    Acta Ophthalmol. 2018 Oct 3. doi: 10.1111/aos.13905.
    PubMed     Text format    

  3. HAFNER J, Karst S, Sacu S, Scholda C, et al
    Correlation between corneal and retinal neurodegenerative changes and their association with microvascular perfusion in type II diabetes.
    Acta Ophthalmol. 2018 Oct 11. doi: 10.1111/aos.13938.
    PubMed     Text format     Abstract available


    Am J Ophthalmol

  4. PAN J, Chen D, Yang X, Zou R, et al
    Characteristics of Neovascularization in Early Stages of Proliferative Diabetic Retinopathy by Optical Coherence Tomography Angiography.
    Am J Ophthalmol. 2018 Oct 6. pii: S0002-9394(18)30504.
    PubMed     Text format    

  5. DANNI R, Taipale C, Ilveskoski L, Tuuminen R, et al
    Diabetes alone does not impair recovery from uneventful cataract surgery.
    Am J Ophthalmol. 2018 Oct 8. pii: S0002-9394(18)30572.
    PubMed     Text format     Abstract available

  6. CHOWDHARY N, Shrivastav A, Koundanya VV, Mayor R, et al
    Characteristics of Neovascularization in Early Stages of Proliferative Diabetic Retinopathy by Optical Coherence Tomography Angiography.
    Am J Ophthalmol. 2018 Oct 5. pii: S0002-9394(18)30503.
    PubMed     Text format    

  7. PARRAVANO M, De Geronimo D, Scarinci F, Virgili G, et al
    Progression of diabetic microaneurysms according to the internal reflectivity on structural OCT and visibility on OCT angiography.
    Am J Ophthalmol. 2018 Oct 8. pii: S0002-9394(18)30573.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  8. WANG L, Luo T, Bao Z, Li Y, et al
    Intrathecal circHIPK3 shRNA alleviates neuropathic pain in diabetic rats.
    Biochem Biophys Res Commun. 2018 Oct 1. pii: S0006-291X(18)32091.
    PubMed     Text format     Abstract available


    Diabet Med

  9. MONTVIDA O, Green JB, Atherton J, Paul SK, et al
    Treatment with incretins does not increase the risk of pancreatic diseases compared to older anti-hyperglycaemic drugs, when added to metformin: real world evidence in people with Type 2 diabetes.
    Diabet Med. 2018 Oct 10. doi: 10.1111/dme.13835.
    PubMed     Text format     Abstract available

  10. RONO K, Masalin S, Kautiainen H, Gissler M, et al
    Impact of maternal income on the risk of gestational diabetes mellitus in primiparous women.
    Diabet Med. 2018 Oct 11. doi: 10.1111/dme.13834.
    PubMed     Text format     Abstract available


    Diabetes

  11. MENZAGHI C, Trischitta V
    Erratum. The Adiponectin Paradox for All-Cause and Cardiovascular Mortality. Diabetes 2018;67:12-22.
    Diabetes. 2018 Oct 10. pii: db18-er12a. doi: 10.2337.
    PubMed     Text format    

  12. CHEUNG CYY, Lee CH, Tang CS, Xu A, et al
    Genetic Regulation of Pigment Epithelium-Derived Factor (PEDF): An Exome-Chip Association Analysis in Chinese Subjects with Type 2 Diabetes.
    Diabetes. 2018 Oct 10. pii: db18-0500. doi: 10.2337/db18-0500.
    PubMed     Text format     Abstract available

  13. ENDESFELDER D, Castell WZ, Bonifacio E, Rewers M, et al
    Time-Resolved Autoantibody Profiling Facilitates Stratification of Preclinical Type 1 Diabetes in Children.
    Diabetes. 2018 Oct 10. pii: db18-0594. doi: 10.2337/db18-0594.
    PubMed     Text format     Abstract available

  14. BOLAND BB, Brown C Jr, Boland ML, Cann J, et al
    Pancreatic beta-Cell Rest Replenishes Insulin Secretory Capacity and Attenuates Diabetes in an Extreme Model of Obese Type 2 Diabetes.
    Diabetes. 2018 Oct 10. pii: db18-0304. doi: 10.2337/db18-0304.
    PubMed     Text format     Abstract available


    Diabetes Care

  15. XIANG AH, Trigo E, Martinez M, Katkhouda N, et al
    Impact of Gastric Banding Versus Metformin on beta-Cell Function in Adults With Impaired Glucose Tolerance or Mild Type 2 Diabetes.
    Diabetes Care. 2018 Oct 3. pii: dc18-1662. doi: 10.2337/dc18-1662.
    PubMed     Text format     Abstract available

  16. ROSENSTOCK J, Marquard J, Laffel LM, Neubacher D, et al
    Empagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes: The EASE Trials.
    Diabetes Care. 2018 Oct 4. pii: dc18-1749. doi: 10.2337/dc18-1749.
    PubMed     Text format     Abstract available

  17. DAVIES MJ, D'Alessio DA, Fradkin J, Kernan WN, et al
    Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
    Diabetes Care. 2018 Oct 4. pii: dci18-0033. doi: 10.2337/dci18-0033.
    PubMed     Text format     Abstract available

  18. EHRMANN D, Kulzer B, Schipfer M, Lippmann-Grob B, et al
    Efficacy of an Education Program for People With Diabetes and Insulin Pump Treatment (INPUT): Results From a Randomized Controlled Trial.
    Diabetes Care. 2018 Oct 10. pii: dc18-0917. doi: 10.2337/dc18-0917.
    PubMed     Text format     Abstract available

  19. PORCELLATI F, Lucidi P, Candeloro P, Cioli P, et al
    Pharmacokinetics, Pharmacodynamics, and Modulation of Hepatic Glucose Production With Insulin Glargine U-300 and Glargine U-100 at Steady State With Individualized Clinical Doses in Type 1 Diabetes.
    Diabetes Care. 2018 Oct 10. pii: dc18-0706. doi: 10.2337/dc18-0706.
    PubMed     Text format     Abstract available

  20. ANDERSEN ST, Witte DR, Fleischer J, Andersen H, et al
    Risk Factors for the Presence and Progression of Cardiovascular Autonomic Neuropathy in Type 2 Diabetes: ADDITION-Denmark.
    Diabetes Care. 2018 Oct 10. pii: dc18-1411. doi: 10.2337/dc18-1411.
    PubMed     Text format     Abstract available

  21. WRIGHT JJ, Salem JE, Johnson DB, Lebrun-Vignes B, et al
    Increased Reporting of Immune Checkpoint Inhibitor-Associated Diabetes.
    Diabetes Care. 2018 Oct 10. pii: dc18-1465. doi: 10.2337/dc18-1465.
    PubMed     Text format    

  22. SHRESTHA SS, Honeycutt AA, Yang W, Zhang P, et al
    Economic Costs Attributable to Diabetes in Each U.S. State.
    Diabetes Care. 2018 Oct 10. pii: dc18-1179. doi: 10.2337/dc18-1179.
    PubMed     Text format     Abstract available


    Diabetes Educ

  23. MICHALISZYN SF, Higgins M, Faulkner MS
    Patterns of Physical Activity Adherence by Adolescents With Diabetes or Obesity Enrolled in a Personalized Community-Based Intervention.
    Diabetes Educ. 2018 Oct 11:145721718805693. doi: 10.1177/0145721718805693.
    PubMed     Text format     Abstract available

  24. VIGEN CLP, Carandang K, Blanchard J, Sequeira PA, et al
    Psychosocial and Behavioral Correlates of A1C and Quality of Life Among Young Adults With Diabetes.
    Diabetes Educ. 2018 Oct 8:145721718804170. doi: 10.1177/0145721718804170.
    PubMed     Text format     Abstract available


    Diabetes Obes Metab

  25. MULDER S, Hamidi H, Kretzler M, Ju W, et al
    An integrative systems biology approach for precision medicine in diabetic kidney disease.
    Diabetes Obes Metab. 2018;20 Suppl 3:6-13.
    PubMed     Text format     Abstract available

  26. CHO KYG, Nakamura A, Omori K, Takase T, et al
    Effect of switching from pioglitazone to the SGLT2 inhibitor dapagliflozin on body weight and metabolism-related factors in patients with type-2 diabetes mellitus: An open-label, prospective, randomized, parallel-group comparison trial.
    Diabetes Obes Metab. 2018 Oct 12. doi: 10.1111/dom.13557.
    PubMed     Text format     Abstract available

  27. AL-QAISSI A, Papageorgiou M, Javed Z, Heise T, et al
    Environmental effects of ambient temperature and relative humidity on insulin pharmacodynamics in adults with type 1 diabetes mellitus.
    Diabetes Obes Metab. 2018 Oct 12. doi: 10.1111/dom.13555.
    PubMed     Text format     Abstract available

  28. GARCIA-FINANA M, Hughes DM, Cheyne CP, Broadbent DM, et al
    Personalized risk-based screening for diabetic retinopathy: a multivariate approach vs. the use of stratification rules.
    Diabetes Obes Metab. 2018 Oct 3. doi: 10.1111/dom.13552.
    PubMed     Text format     Abstract available

  29. MAGALHAES JP, Judice PB, Ribeiro R, Andrade R, et al
    Effectiveness of high intensity interval training combined with resistance training vs. continuous moderate intensity training combined with resistance training in patients with type 2 diabetes - 1 year randomized controlled trial.
    Diabetes Obes Metab. 2018 Oct 3. doi: 10.1111/dom.13551.
    PubMed     Text format     Abstract available

  30. BAIN SC, Mosenzon O, Arechavaleta R, Bogdanski P, et al
    Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial.
    Diabetes Obes Metab. 2018 Oct 4. doi: 10.1111/dom.13553.
    PubMed     Text format     Abstract available

  31. DE VRIES JK, Levin A, Loud F, Adler A, et al
    Implementing personalized medicine in diabetic kidney disease: Stakeholders' perspectives.
    Diabetes Obes Metab. 2018;20 Suppl 3:24-29.
    PubMed     Text format     Abstract available

  32. MOL PGM, Thompson A, Heerspink HJL, Leufkens HGM, et al
    Precision medicine in diabetes and diabetic kidney disease: Regulatory considerations.
    Diabetes Obes Metab. 2018;20 Suppl 3:19-23.
    PubMed     Text format     Abstract available

  33. HEERSPINK HJL, de Zeeuw D
    Treating diabetic complications; from large randomized clinical trials to precision medicine.
    Diabetes Obes Metab. 2018;20 Suppl 3:3-5.
    PubMed     Text format     Abstract available

  34. BJORNSTAD P, Singh SK, Snell-Bergeon JK, Lovshin JA, et al
    The Relationships between Markers of Tubular Injury and Intrarenal Hemodynamic Function in Adults with and without Type 1 Diabetes: Results from the Canadian Study of Longevity in Type 1 Diabetes.
    Diabetes Obes Metab. 2018 Oct 12. doi: 10.1111/dom.13556.
    PubMed     Text format     Abstract available


    Diabetologia

  35. GAEDE J, Oellgaard J, Ibsen R, Gaede P, et al
    A cost analysis of intensified vs conventional multifactorial therapy in individuals with type 2 diabetes: a post hoc analysis of the Steno-2 study.
    Diabetologia. 2018 Oct 6. pii: 10.1007/s00125-018-4739.
    PubMed     Text format     Abstract available

  36. LI J, Rice MS, Huang T, Hankinson SE, et al
    Circulating prolactin concentrations and risk of type 2 diabetes in US women.
    Diabetologia. 2018 Oct 11. pii: 10.1007/s00125-018-4733.
    PubMed     Text format     Abstract available

  37. COLOMBO M, Looker HC, Farran B, Hess S, et al
    Serum kidney injury molecule 1 and beta2-microglobulin perform as well as larger biomarker panels for prediction of rapid decline in renal function in type 2 diabetes.
    Diabetologia. 2018 Oct 5. pii: 10.1007/s00125-018-4741.
    PubMed     Text format     Abstract available

  38. RUSSELL AW, Donald M, Borg SJ, Zhang J, et al
    Clinical outcomes of an integrated primary-secondary model of care for individuals with complex type 2 diabetes: a non-inferiority randomised controlled trial.
    Diabetologia. 2018 Oct 3. pii: 10.1007/s00125-018-4740.
    PubMed     Text format     Abstract available

  39. DAVIES MJ, D'Alessio DA, Fradkin J, Kernan WN, et al
    Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
    Diabetologia. 2018 Oct 5. pii: 10.1007/s00125-018-4729.
    PubMed     Text format     Abstract available


    J Am Coll Cardiol

  40. DEEDWANIA P
    Dangers of Hypoglycemia in Cardiac Patients With Diabetes: Time to Switch to Safer, Newer Drugs.
    J Am Coll Cardiol. 2018;72:1787-1789.
    PubMed     Text format    

  41. NEWMAN JD, Vani AK, Aleman JO, Weintraub HS, et al
    The Changing Landscape of Diabetes Therapy for Cardiovascular Risk Reduction: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2018;72:1856-1869.
    PubMed     Text format     Abstract available

  42. REZENDE PC, Everett BM, Brooks MM, Vlachos H, et al
    Hypoglycemia and Elevated Troponin in Patients With Diabetes and Coronary Artery Disease.
    J Am Coll Cardiol. 2018;72:1778-1786.
    PubMed     Text format     Abstract available


    J Autoimmun

  43. ALPER CA, Larsen CE, Trautwein MR, Alford DR, et al
    A stochastic epigenetic Mendelian oligogenic disease model for type 1 diabetes.
    J Autoimmun. 2018 Oct 8. pii: S0896-8411(18)30427.
    PubMed     Text format     Abstract available


    J Clin Endocrinol Metab

  44. LONDERO TM, Giaretta LS, Penso Farenzena L, Manfro R, et al
    Microvascular Complications of Posttransplant Diabetes Mellitus in Kidney Transplant Recipients: a Longitudinal Study Posttransplant Diabetes Complications.
    J Clin Endocrinol Metab. 2018 Oct 4. pii: 5114465. doi: 10.1210/jc.2018-01521.
    PubMed     Text format     Abstract available


    J Diabetes Complications

  45. BRITTON LE, Berry DC, Hussey JM
    Comorbid hypertension and diabetes among U.S. women of reproductive age: Prevalence and disparities.
    J Diabetes Complications. 2018 Sep 26. pii: S1056-8727(18)30871.
    PubMed     Text format     Abstract available

  46. JANSEN RB, Jorgensen B, Holstein PE, Moller KK, et al
    Mortality and complications after treatment of acute diabetic Charcot foot.
    J Diabetes Complications. 2018 Sep 29. pii: S1056-8727(18)30357.
    PubMed     Text format     Abstract available

  47. ANDERSEN ST, Grosen K, Tankisi H, Charles M, et al
    Corneal confocal microscopy as a tool for detecting diabetic polyneuropathy in a cohort with screen-detected type 2 diabetes: ADDITION-Denmark.
    J Diabetes Complications. 2018 Oct 1. pii: S1056-8727(18)30519.
    PubMed     Text format     Abstract available

  48. ZEKARIAS K, Kumar A, Moheet A, Seaquist E, et al
    Real life evidence that impaired awareness of hypoglycemia persists for years in patients with type 1 diabetes.
    J Diabetes Complications. 2018 Sep 1. pii: S1056-8727(18)30511.
    PubMed     Text format     Abstract available

  49. SAKURAI K, Kawai Y, Yamazaki M, Komatsu M, et al
    Prediction of lowest nocturnal blood glucose level based on self-monitoring of blood glucose in Japanese patients with type 2 diabetes.
    J Diabetes Complications. 2018 Sep 13. pii: S1056-8727(18)30596.
    PubMed     Text format     Abstract available

  50. OELLGAARD J, Gaede P, Persson F, Rossing P, et al
    Application of urinary proteomics as possible risk predictor of renal and cardiovascular complications in patients with type 2-diabetes and microalbuminuria.
    J Diabetes Complications. 2018 Sep 24. pii: S1056-8727(18)30747.
    PubMed     Text format     Abstract available


    JAMA

  51. PENG S, Li C, Sun X
    Glyburide vs Insulin for Gestational Diabetes.
    JAMA. 2018;320:1383-1384.
    PubMed     Text format    

  52. SENAT MV, Affres H, Bouyer J
    Glyburide vs Insulin for Gestational Diabetes-Reply.
    JAMA. 2018;320:1384.
    PubMed     Text format    


    Lancet

  53. HERNANDEZ AF, Green JB, Janmohamed S, D'Agostino RB Sr, et al
    Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.
    Lancet. 2018 Oct 1. pii: S0140-6736(18)32261.
    PubMed     Text format     Abstract available

  54. BOHULA EA, Scirica BM, Inzucchi SE, McGuire DK, et al
    Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial.
    Lancet. 2018 Oct 3. pii: S0140-6736(18)32328.
    PubMed     Text format     Abstract available

  55. FRIAS JP, Nauck MA, Van J, Kutner ME, et al
    Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial.
    Lancet. 2018 Oct 3. pii: S0140-6736(18)32260.
    PubMed     Text format     Abstract available

  56. GALDERISI A, Sherr JL
    Enlarging the loop: closed-loop insulin delivery for type 1 diabetes.
    Lancet. 2018 Oct 1. pii: S0140-6736(18)32329.
    PubMed     Text format    

  57. TAUSCHMANN M, Thabit H, Bally L, Allen JM, et al
    Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial.
    Lancet. 2018 Oct 1. pii: S0140-6736(18)31947.
    PubMed     Text format     Abstract available


    Lancet Diabetes Endocrinol

  58. MUSKIET MHA, Tonneijck L, Huang Y, Liu M, et al
    Lixisenatide and renal outcomes in patients with type 2 diabetes and acute coronary syndrome: an exploratory analysis of the ELIXA randomised, placebo-controlled trial.
    Lancet Diabetes Endocrinol. 2018 Oct 1. pii: S2213-8587(18)30268.
    PubMed     Text format     Abstract available

  59. HILLS AP, Arena R, Khunti K, Yajnik CS, et al
    Epidemiology and determinants of type 2 diabetes in south Asia.
    Lancet Diabetes Endocrinol. 2018 Oct 1. pii: S2213-8587(18)30204.
    PubMed     Text format     Abstract available

  60. MISRA A, Sattar N, Tandon N, Shrivastava U, et al
    Clinical management of type 2 diabetes in south Asia.
    Lancet Diabetes Endocrinol. 2018 Oct 1. pii: S2213-8587(18)30199.
    PubMed     Text format     Abstract available

  61. HILLS AP, Misra A, Gill JMR, Byrne NM, et al
    Public health and health systems: implications for the prevention and management of type 2 diabetes in south Asia.
    Lancet Diabetes Endocrinol. 2018 Oct 1. pii: S2213-8587(18)30203.
    PubMed     Text format     Abstract available


    Med Care

  62. RITCHIE ND, Gritz RM
    New Medicare Diabetes Prevention Coverage May Limit Beneficiary Access and Widen Health Disparities.
    Med Care. 2018;56:908-911.
    PubMed     Text format     Abstract available


    N Engl J Med

  63. BOHULA EA, Wiviott SD, McGuire DK, Inzucchi SE, et al
    Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients.
    N Engl J Med. 2018 Aug 26. doi: 10.1056/NEJMoa1808721.
    PubMed     Text format     Abstract available


    Nat Genet

  64. COUSMINER DL, Grant SFA
    Public resources aid diabetes gene discovery.
    Nat Genet. 2018 Oct 8. pii: 10.1038/s41588-018-0242.
    PubMed     Text format    

  65. MAHAJAN A, Taliun D, Thurner M, Robertson NR, et al
    Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps.
    Nat Genet. 2018 Oct 8. pii: 10.1038/s41588-018-0241.
    PubMed     Text format     Abstract available


    Ophthalmology

  66. MALONEY MH, Schilz SR, Herrin J, Sangaralingham LR, et al
    Risk of Systemic Adverse Events Associated with Intravitreal Anti-VEGF Therapy for Diabetic Macular Edema in Routine Clinical Practice.
    Ophthalmology. 2018 Oct 4. pii: S0161-6420(18)30063.
    PubMed     Text format     Abstract available


    Pediatr Diabetes

  67. MALONE JI, Hansen BC
    Does Obesity Cause Type 2 Diabetes? OR Is it the Opposite? A Commentary.
    Pediatr Diabetes. 2018 Oct 12. doi: 10.1111/pedi.12787.
    PubMed     Text format     Abstract available

  68. MUELLER-GODEFFROY E, Vonthein R, Ludwig-Seibold C, Heidtmann B, et al
    Psychosocial benefits of insulin pump therapy in children with diabetes type 1 and their families: The pumpkin multicenter randomized controlled trial.
    Pediatr Diabetes. 2018 Oct 10. doi: 10.1111/pedi.12777.
    PubMed     Text format     Abstract available


  69. Abstracts for the 44th Annual Meeting of the International Society for Pediatric and Adolescent Diabetes (ISPAD), 11-14 October 2018, Hyderabad, India.
    Pediatr Diabetes. 2018;19 Suppl 26:3-150.
    PubMed     Text format    

  70. GOSS PW, Middlehurst A, Acerini CL, Anderson BJ, et al
    ISPAD Position Statement on Type 1 Diabetes in Schools.
    Pediatr Diabetes. 2018;19:1338-1341.
    PubMed     Text format    


  71. Statement on Unproven Therapies for Type 1 Diabetes.
    Pediatr Diabetes. 2018;19:1337.
    PubMed     Text format    

  72. CAMERON F, Moore B, Gillam L
    Two's company, is three a crowd? Ethical cognition in decision making and the role of industry third parties in pediatric diabetes care.
    Pediatr Diabetes. 2018 Oct 12. doi: 10.1111/pedi.12786.
    PubMed     Text format     Abstract available


    PLoS Med

  73. IMAMURA F, Fretts A, Marklund M, Ardisson Korat AV, et al
    Fatty acid biomarkers of dairy fat consumption and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies.
    PLoS Med. 2018;15:e1002670.
    PubMed     Text format     Abstract available


    PLoS One

  74. YEN FS, Chen W, Wei JC, Hsu CC, et al
    Effects of metformin use on total mortality in patients with type 2 diabetes and chronic obstructive pulmonary disease: A matched-subject design.
    PLoS One. 2018;13:e0204859.
    PubMed     Text format     Abstract available

  75. MENDEZ-LARA KA, Santos D, Farre N, Ruiz-Nogales S, et al
    Administration of CORM-2 inhibits diabetic neuropathy but does not reduce dyslipidemia in diabetic mice.
    PLoS One. 2018;13:e0204841.
    PubMed     Text format     Abstract available

  76. BOUTCHUENG-DJIDJOU M, Belleau P, Bilodeau N, Fortier S, et al
    A type 2 diabetes disease module with a high collective influence for Cdk2 and PTPLAD1 is localized in endosomes.
    PLoS One. 2018;13:e0205180.
    PubMed     Text format     Abstract available

  77. TAKAHASHI T, Yoshihisa A, Sugimoto K, Yokokawa T, et al
    Associations between diabetes mellitus and pulmonary hypertension in chronic respiratory disease patients.
    PLoS One. 2018;13:e0205008.
    PubMed     Text format     Abstract available

  78. TSUZUKI T, Yoshihara T, Ichinoseki-Sekine N, Kakigi R, et al
    Body temperature elevation during exercise is essential for activating the Akt signaling pathway in the skeletal muscle of type 2 diabetic rats.
    PLoS One. 2018;13:e0205456.
    PubMed     Text format     Abstract available

  79. EL SADIK A, Mohamed E, El Zainy A
    Postnatal changes in the development of rat submandibular glands in offspring of diabetic mothers: Biochemical, histological and ultrastructural study.
    PLoS One. 2018;13:e0205372.
    PubMed     Text format     Abstract available

  80. PARK M, Moon WJ, Moon Y, Choi JW, et al
    Region-specific susceptibility change in cognitively impaired patients with diabetes mellitus.
    PLoS One. 2018;13:e0205797.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  81. SHEHATA HM, Khan S, Chen E, Fields PE, et al
    Lack of Sprouty 1 and 2 enhances survival of effector CD8(+) T cells and yields more protective memory cells.
    Proc Natl Acad Sci U S A. 2018;115:E8939-E8947.
    PubMed     Text format     Abstract available

  82. GASSAWAY BM, Petersen MC, Surovtseva YV, Barber KW, et al
    PKCepsilon contributes to lipid-induced insulin resistance through cross talk with p70S6K and through previously unknown regulators of insulin signaling.
    Proc Natl Acad Sci U S A. 2018;115:E8996-E9005.
    PubMed     Text format     Abstract available


    Retina

  83. HECHT I, Bar A, Rokach L, Noy Achiron R, et al
    OPTICAL COHERENCE TOMOGRAPHY BIOMARKERS TO DISTINGUISH DIABETIC MACULAR EDEMA FROM PSEUDOPHAKIC CYSTOID MACULAR EDEMA USING MACHINE LEARNING ALGORITHMS.
    Retina. 2018 Oct 3. doi: 10.1097/IAE.0000000000002342.
    PubMed     Text format     Abstract available

  84. MIDENA E, Bini S, Martini F, Enrica C, et al
    CHANGES OF AQUEOUS HUMOR MULLER CELLS' BIOMARKERS IN HUMAN PATIENTS AFFECTED BY DIABETIC MACULAR EDEMA AFTER SUBTHRESHOLD MICROPULSE LASER TREATMENT.
    Retina. 2018 Oct 8. doi: 10.1097/IAE.0000000000002356.
    PubMed     Text format     Abstract available

  85. TASLIPINAR UZEL AG, UGurlu N, Toklu Y, CIcek M, et al
    RELATIONSHIP BETWEEN STAGES OF DIABETIC RETINOPATHY AND LEVELS OF BRAIN-DERIVED NEUROTROPHIC FACTOR IN AQUEOUS HUMOR AND SERUM.
    Retina. 2018 Oct 8. doi: 10.1097/IAE.0000000000002355.
    PubMed     Text format     Abstract available

  86. PANG JP, Son G, Yoon YH, Kim JG, et al
    COMBINED VITRECTOMY WITH INTRAVITREAL DEXAMETHASONE IMPLANT FOR REFRACTORY MACULAR EDEMA SECONDARY TO DIABETIC RETINOPATHY, RETINAL VEIN OCCLUSION, AND NONINFECTIOUS POSTERIOR UVEITIS.
    Retina. 2018 Oct 10. doi: 10.1097/IAE.0000000000002358.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: